Navigation Links
PharmAthene to Host Third Quarter 2008 Conference Call and Webcast on Thursday, November 13, 2008
Date:11/6/2008

ANNAPOLIS, Md., Nov. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE: PIP) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the third quarter of 2008 will be released on Thursday, November 13, 2008.

PharmAthene management will be hosting a conference call to discuss its third quarter 2008 financial results. The call is scheduled to begin at 4:30 p.m. Eastern Time on Thursday, November 13, 2008 and will last approximately 45 minutes.

The dial-in number for U.S. callers is 800-798-2801 and for international callers is 617-614-6205. The participant passcode is 81927054.

A replay of the conference call will be available for 30 days, beginning at approximately 6:30 p.m. E.T. on November 13, 2008 until approximately 11:50 p.m. E.T. December 13, 2008. The dial-in number for U.S. callers is 888-286-8010, and for international callers is 617-801-6888. The participant passcode is 74215682.

The webcast of the conference call can be accessed from the company's website at http://www.pharmathene.com . A link to the webcast may be found on the Investor Relations section of the website.

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

-- SparVax(TM) -- a second generation recombinant protective antigen (rPA)

anthrax vaccine

-- Third generation rPA anthrax vaccine

-- Valortim(R) -- a fully human monoclonal antibody f
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. PharmAthene to Present on Wednesday, November 12th at the 10th Annual Rodman & Renshaw Healthcare Conference
2. Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
3. PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases
4. PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program
5. PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008
6. PharmAthene to Present at the UBS Global Life Sciences Conference on Thursday September 25, 2008
7. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
8. PharmAthene Reports Second Quarter 2008 Financial and Operational Results
9. Lord Lewis Moonie to Serve as Special UK Government Advisor to PharmAthene
10. PharmAthene Appoints Jordan P. Karp, J.D. Senior Vice President and General Counsel
11. PharmAthene Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... CORALVILLE, Iowa, Dec. 10 Vivakor, ... that it has entered into an exclusive, ... specialist, Regeneca International, Inc. ( www.regeneca.com ). ... distribution rights to a new cutting-edge nutraceutical ... the development of future formulations by Vivakor ...
(Date:12/10/2009)... Biomatrica, the leader in room temperature ... SampleWare 3.1 software system for laboratory inventory, organization ... now includes an audit trail functionality that tracks ... complete history of any stored sample. ,, ... customers a much needed ability to track all ...
(Date:12/10/2009)... SEATTLE, Dec. 10 Dendreon Corporation (Nasdaq: ... the Company as chief operating officer, effective January 4, ... of the specialty medicine business at Bayer, where he ... and neurology products. Mr. Bishop also served as ... ,, As a member of the Dendreon executive management ...
(Date:12/10/2009)... Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) ... company,s Board of Directors. Mr. Farmer, a graduate ... on six other corporate boards. ,, Mr. ... campaigns, including those of John Kerry, Bill Clinton, Michael ... led fundraising of over $800 million. He served ...
Breaking Biology Technology:Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3Biomatrica Launches SampleWare 3.1 2Biomatrica Launches SampleWare 3.1 3Dendreon Appoints Hans Bishop as Chief Operating Officer 2Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 2Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 3
... 1 April was Wall Street,s best month in nine ... the economy is about to begin a turnaround. The Dow ... in April, on top of a 7.7 percent gain in ... as investors were not phased by a World Health Organization ...
... Increase of 29% over First Quarter 2008- Earnings Per Share ... Increases of 14% and 20% over First Quarter 2008, respectively ... UTHR ) today announced its results of operations ... for the first quarter of 2009 were $79.7 million, up ...
... and Student Research, Partnering with Industry , ... ... University of Massachusetts Boston today officially opened a cutting-edge ... university,s research and development activity and provide entrepreneurial opportunities for ...
Other Biology Technology:Biotech Drops on Weaker First Quarter Drug Sales, But Broader Markets Remain on a Roll 2Biotech Drops on Weaker First Quarter Drug Sales, But Broader Markets Remain on a Roll 3United Therapeutics Reports First Quarter 2009 Financial Results 2United Therapeutics Reports First Quarter 2009 Financial Results 3United Therapeutics Reports First Quarter 2009 Financial Results 4United Therapeutics Reports First Quarter 2009 Financial Results 5United Therapeutics Reports First Quarter 2009 Financial Results 6United Therapeutics Reports First Quarter 2009 Financial Results 7UMass Boston Opens Venture Development Center to Expand R&D Activity 2UMass Boston Opens Venture Development Center to Expand R&D Activity 3UMass Boston Opens Venture Development Center to Expand R&D Activity 4
(Date:12/13/2009)... five genetic variants that are associated with the health ... consortium of 96 scientists from 63 centres in Europe ... of lung diseases. , The new findings provide hope ... Pulmonary Disease (COPD) and asthma. In the past it ... molecular pathways that affect the health of the lung ...
(Date:12/11/2009)... BATON ROUGE, LAKeeping with the global "green" ... environmental education lessons to enhance students, science ... education into the curriculum raises not just ... test scores in other subject areas. Naturally, ... to integrate these relevant lessons into the ...
(Date:12/11/2009)... wild apples that could be an ancestor of today,s ... Asia. A new study comparing the diversity of recently ... Armenia with previously collected varieties originating in Russia and ... collection that will make M. orientalis more ... identify and record the genetic diversity of these wild ...
Breaking Biology News(10 mins):New genes for lung disease discovered 2Students learn environmental stewardship, improve science scores 2Understanding apples' ancestors 2Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 1Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 2Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 3HOYA ConBio Announces Educational Alliance with LVI Global Australia 55683 1HOYA ConBio Announces Educational Alliance with LVI Global Australia 55683 2Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 1Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 2
... the genetics of barley could lead to improved varieties ... of whisky and beer. Scientists funded in part by ... beginning a new programme to uncover key genes that ... The research, being carried out at the Scottish Crop ...
... game between pathogens and the hosts they infect, researchers have ... recently discovered gene silencing device to evade detection and destruction ... Institute (HHMI) researchers in an article published in the June ... show how a virus uses the gene silencing machinery for ...
... the Sinclair gasoline logo and Fred Flintstone's gravel pit tractor---are ... look alike. , The largest animals known to have ... the middle of the dinosaur era but were thought to ... the end of that era. New discoveries, however, are showing ...
Other Biology News:Whisky fans can drink to crop research 2Virus uses tiny RNA to evade the immune system 2Virus uses tiny RNA to evade the immune system 3Skull study sheds light on dinosaur diversity 2Skull study sheds light on dinosaur diversity 3
... Strain Competent Cell Sets Sets of ... combinations The most common method ... coli is to use chemically competent ... in the laboratory, greater efficiency, reproducibility and ...
... The BD Pathway Bioimager is an automated, ... imaging system that has been integrated into ... Pathway was designed to provide high-resolution, automated ... assist in developing better cell-based assays. The ...
... Imager delivers high resolution CCD confocal imaging ... effective optical package that fits on your ... combined with high quantum efficiency CCD cameras, ... recording at up to 100 fps. A ...
... Methylation Kit uses a simplified procedure and ... analysis. The kit is based on the ... cytosine and sodium bisulfite where cytosine is ... Kits innovative in-column desulphonation reaction eliminates several ...
Biology Products: